Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance

  //health-fitness.news-articles.net/content/2011/ .. ce-call-to-announce-2012-financial-guidance.html
  Published in Health and Fitness on Thursday, December 22nd 2011 at 5:21 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance -- MISSISSAUGA, Ontario, Dec. 22, 2011 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about VRX

[ ]

[ Download image ]

MISSISSAUGA, Ontario, Dec. 22, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: [ VRX ]) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Friday, January 6, 2012 at 10:00 a.m. EST (7:00 a.m. PST) to announce 2012 financial guidance.

The dial-in number to participate on this call is (877) 295-5743, confirmation code37652661.  International callers should dial (973) 200-3961, confirmation code 37652661. A replay will be available approximately two hours following the conclusion of the conference call to Friday, January 13, 2011, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 37652661.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at [ www.valeant.com ]. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at [ www.valeant.com ].

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at [ www.valeant.com ].

(Logo:  [ http://photos.prnewswire.com/prnh/20101025/LA87217LOGO ])

Contact Information:
Laurie W. Little
949-461-6002
[ laurie.little@valeant.com ]

SOURCE Valeant Pharmaceuticals International, Inc.

RELATED LINKS
[ http://www.valeant.com ]